Celecoxib can prevent capecitabine-related hand-foot syndrome in stage II and III colorectal cancer patients: result of a single-center, prospective randomized phase III trial

Autor: Zhang, R.X., Wu, X.J., Wan, D.S., Lu, Z.H., Kong, L.H., Pan, Z.Z. *, Chen, G. *
Zdroj: In Annals of Oncology May 2012 23(5):1348-1353
Databáze: ScienceDirect